Senseonics Holdings Inc (SENS) - News Archive

Senseonics Charts a New Course: Memorandum of Understanding with Ascensia Diabetes Care and Strong Revenue Growth Amid Market CompetitionIn a strategic move poised to reshape its commercial landscape, Senseonics Holding...

In a significant update from Germantown, Md. Senseonics Holdings, Inc. (NYSE American: SENS), a pioneering enterprise in medical technology, announced its latest operational and financial developments on January 8, 2025...

Eversense 365: A Promising Launch Amidst Market Challenges for Senseonics Holdings Senseonics Holdings, Inc. a company devoted to revolutionising diabetes management through innovative glucose-monitoring technology, has...

Senseonics Hosts Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World s First One-Year CGM System In an exciting development in the field of continuous glucose monitoring (CGM) tec...

Revolutionizing Diabetes Management: Mercy s First Commercial Rollout of the Eversense 365 Continuous Glucose Monitor In a significant stride toward enhancing diabetes management, Mercy, a prominent healthcare provider,...

In a major advancement for diabetes management, Senseonics Holdings Inc. has received FDA clearance for its groundbreaking Eversense 365, marking it as the world s first integrated continuous glucose monitoring (iCGM) s...